STAT+: Pharmalittle: We're reading about the FDA speeding up trials, a Supreme Court hearing on 'skinny labels,' and more

The FDA is implementing real-time data review from clinical trials conducted by AstraZeneca and Amgen, aiming to streamline trial processes. This development benefits tech professionals by setting a precedent for integrating AI in safety monitoring and patient recruitment, potentially reducing regulatory delays. Watch for the outcomes of the pilot program using Paradigm Health's platform.

Read the full article at STAT Pharma

---

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.